{"transactions":[{"id":764233,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-26T20:49:51.000Z","date":"2026-05-22","kind":"purchase","planned":false,"acquired":true,"shares":153000,"price":16.37,"value":2504610.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $16.29 to $16.45, inclusive. The reporting person undertakes to provide to Norwegian Cruise Line Holdings Ltd. (\"NCLH\"), any security holder of NCLH, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":1139940,"source":{"system":"sec-edgar","filing":"0001104659-26-066326","document":"tm2615646-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000110465926066326/tm2615646-1_4seq1.xml","form_type":"4"}},{"id":797424,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T16:57:26.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common stock underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date."}],"balance_after":1305,"source":{"system":"sec-edgar","filing":"0001193125-26-197734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526197734/ownership.xml","form_type":"4"}},{"id":826682,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Share Units","published_at":"2026-03-27T21:00:36.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":1172638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents a grant of performance-based restricted share units pursuant to the Award Agreement. Each performance-based restricted share unit represents a contingent right to receive between zero and two Ordinary Shares of NCLH, depending on NCLH's total shareholder return compound annual growth rate achieved during the performance period ending December 31, 2029. The number reported reflects the target number of shares underlying the performance-based restricted share units and is subject to the Reporting Person's continued employment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a grant of performance-based restricted share units pursuant to the Award Agreement. Each performance-based restricted share unit represents a contingent right to receive between zero and two Ordinary Shares of NCLH, depending on NCLH's total shareholder return compound annual growth rate achieved during the performance period ending December 31, 2029. The number reported reflects the target number of shares underlying the performance-based restricted share units and is subject to the Reporting Person's continued employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents a grant of performance-based restricted share units pursuant to the Award Agreement. Each performance-based restricted share unit represents a contingent right to receive between zero and two Ordinary Shares of NCLH, depending on NCLH's total shareholder return compound annual growth rate achieved during the performance period ending December 31, 2029. The number reported reflects the target number of shares underlying the performance-based restricted share units and is subject to the Reporting Person's continued employment."}],"balance_after":1172638,"derivative":{"underlying":"Common Stock","underlying_shares":1172638},"source":{"system":"sec-edgar","filing":"0001104659-26-036211","document":"tm2610056-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000110465926036211/tm2610056-1_4seq1.xml","form_type":"4"}},{"id":826681,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-27T21:00:36.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":967254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted share unit represents the contingent right to receive one ordinary share of Norwegian Cruise Line Holdings Ltd. (\"NCLH\") upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted share units under a Restricted Share Unit Award Agreement dated March 26, 2026 (the \"Award Agreement\"). The restricted share units will vest in four equal installments on March 1, 2027, March 1, 2028, March 1, 2029, and March 1, 2030, subject to the Reporting Person's continued employment through each applicable vesting date."}],"balance_after":986940,"source":{"system":"sec-edgar","filing":"0001104659-26-036211","document":"tm2610056-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000110465926036211/tm2610056-1_4seq1.xml","form_type":"4"}},{"id":947598,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:18:26.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":13169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted share unit represents the contingent right to receive one share of Norwegian Cruise Line Holdings Ltd.'s (\"NCLH\") common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted share units under NCLH's Amended and Restated 2013 Performance Incentive Plan. The restricted share units will vest in one installment on January 4, 2027."}],"balance_after":19686,"source":{"system":"sec-edgar","filing":"0001104659-26-001318","document":"tm261938-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000110465926001318/tm261938-6_4seq1.xml","form_type":"4"}},{"id":1078698,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-31T18:37:12.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common stock underlying 496 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date."}],"balance_after":496,"source":{"system":"sec-edgar","filing":"0000950170-25-101052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025101052/ownership.xml","form_type":"4"}},{"id":1279056,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-07T21:47:24.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":6517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted share unit represents the contingent right to receive one share of Norwegian Cruise Line Holdings Ltd.'s (\"NCLH\") common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted share units under NCLH's Amended and Restated 2013 Performance Incentive Plan. The restricted share units will vest in one installment on January 2, 2026."}],"balance_after":6517,"source":{"system":"sec-edgar","filing":"0001104659-25-010592","document":"tm255671-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000110465925010592/tm255671-2_4seq1.xml","form_type":"4"}},{"id":1541631,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-04-16T20:36:21.000Z","date":"2024-04-16","kind":"grant","planned":false,"acquired":true,"shares":234,"price":79.52,"value":18607.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2023 to defer fixed percentages of their director fees for 2024. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly fee deferral and the dividend of $0.15 per share paid on April 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.43 to $79.62, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":162826,"source":{"system":"sec-edgar","filing":"0001127602-24-013000","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224013000/form4.xml","form_type":"4"}},{"id":1541630,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-04-16T20:36:21.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $80.73. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":162592,"source":{"system":"sec-edgar","filing":"0001127602-24-013000","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224013000/form4.xml","form_type":"4"}},{"id":1677249,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-01-18T18:25:49.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":495,"price":70.48,"value":34887.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2023 to defer fixed percentages of their directors fees for 2024. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the dividend of $0.15 per share paid on January 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $70.36 to $70.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":162416,"source":{"system":"sec-edgar","filing":"0001127602-24-001540","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224001540/form4.xml","form_type":"4"}},{"id":1677248,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-01-18T18:25:49.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $71.45. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":161921,"source":{"system":"sec-edgar","filing":"0001127602-24-001540","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224001540/form4.xml","form_type":"4"}},{"id":1759476,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-10-17T21:08:12.000Z","date":"2023-10-17","kind":"grant","planned":false,"acquired":true,"shares":541,"price":64.58,"value":34937.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2022 to defer fixed percentages of their director fees for 2023. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly deferred fees and the dividend of $0.15 per share paid on October 16, 2023."}],"balance_after":161722,"source":{"system":"sec-edgar","filing":"0001127602-23-026005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223026005/form4.xml","form_type":"4"}},{"id":1759475,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-10-17T21:08:12.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $63.77. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":161181,"source":{"system":"sec-edgar","filing":"0001127602-23-026005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223026005/form4.xml","form_type":"4"}},{"id":1828273,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-07-18T17:44:23.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":448,"price":67.73,"value":30343.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2022 to defer fixed percentages of their directors fees for 2023. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly deferral and the dividend of $0.15 per share paid on July 17,2023"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $67.70 to $67.74. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":160959,"source":{"system":"sec-edgar","filing":"0001127602-23-020892","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223020892/form4.xml","form_type":"4"}},{"id":1828272,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-07-18T17:44:23.000Z","date":"2023-07-17","kind":"grant","planned":false,"acquired":true,"shares":209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $67.54. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":160511,"source":{"system":"sec-edgar","filing":"0001127602-23-020892","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223020892/form4.xml","form_type":"4"}},{"id":1901697,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-05-08T17:12:20.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":2385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":160302,"source":{"system":"sec-edgar","filing":"0001127602-23-014824","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223014824/form4.xml","form_type":"4"}},{"id":1917657,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-04-19T17:25:29.000Z","date":"2023-04-18","kind":"grant","planned":false,"acquired":true,"shares":687,"price":61.51,"value":42257.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2022 to defer fixed percentages of their directors fees for 2023. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the dividend of $0.15 per share paid on April 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $61.50 to $61.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":157917,"source":{"system":"sec-edgar","filing":"0001127602-23-013216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223013216/form4.xml","form_type":"4"}},{"id":1917656,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-04-19T17:25:29.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":157230,"source":{"system":"sec-edgar","filing":"0001127602-23-013216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223013216/form4.xml","form_type":"4"}},{"id":2051679,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-01-19T16:36:54.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":682,"price":61.65,"value":42045.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2022 to defer fixed percentages of their directors fees for 2023. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly deferral and the dividend of $0.15 per share paid on January 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $61.65 to $61.66, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":157007,"source":{"system":"sec-edgar","filing":"0001127602-23-001737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223001737/form4.xml","form_type":"4"}},{"id":2051678,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-01-19T16:36:54.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.16. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":156325,"source":{"system":"sec-edgar","filing":"0001127602-23-001737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223001737/form4.xml","form_type":"4"}},{"id":2135156,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-10-19T20:43:01.000Z","date":"2022-10-18","kind":"grant","acquired":true,"shares":848,"price":49.73,"value":42171.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2021 to defer fixed percentages of their directors fees for 2022. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly deferral and the dividend of $0.15 per share paid on October 17, 2022."}],"balance_after":156101,"source":{"system":"sec-edgar","filing":"0001127602-22-024168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222024168/form4.xml","form_type":"4"}},{"id":2135155,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-10-19T20:43:01.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2022, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $48.81. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":155253,"source":{"system":"sec-edgar","filing":"0001127602-22-024168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222024168/form4.xml","form_type":"4"}},{"id":2199664,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-08-01T21:14:20.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":1003,"price":50.69,"value":50842.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents the purchase of (a) 654 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 349 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2021 to defer fixed percentages of their directors fees for 2022. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On July 20, 2022, the Company paid a dividend on common stock of $0.28 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $50.67 to $50.73, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":128937,"source":{"system":"sec-edgar","filing":"0001127602-22-020037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222020037/form4.xml","form_type":"4"}},{"id":2204219,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-07-21T20:51:57.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 20, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $49.19. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":127934,"source":{"system":"sec-edgar","filing":"0001127602-22-019591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222019591/form4.xml","form_type":"4"}},{"id":2278532,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-05-09T20:12:33.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":2226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":127420,"source":{"system":"sec-edgar","filing":"0001127602-22-013822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222013822/form4.xml","form_type":"4"}},{"id":2294299,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-04-20T17:49:35.000Z","date":"2022-04-19","kind":"grant","acquired":true,"shares":633,"price":72.33,"value":45784.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 432 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 201 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2021 to defer fixed percentages of their directors fees for 2022. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On April 18, 2022, the Company paid a dividend on common stock of $0.28 per share."}],"balance_after":125194,"source":{"system":"sec-edgar","filing":"0001127602-22-012236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222012236/form4.xml","form_type":"4"}},{"id":2294298,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-04-20T17:49:35.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":124561,"source":{"system":"sec-edgar","filing":"0001127602-22-012236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222012236/form4.xml","form_type":"4"}},{"id":2428247,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-01-24T21:01:07.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":498,"price":62.59,"value":31169.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents the purchase of shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\"). The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2021 to defer fixed percentages of their directors fees for 2022. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $62.59 to $62.60, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":124276,"source":{"system":"sec-edgar","filing":"0001127602-22-001940","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222001940/form4.xml","form_type":"4"}},{"id":2431575,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-01-20T22:03:48.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":231,"price":61.21,"value":14139.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the \"Plan\"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On January 18, 2022, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment."}],"balance_after":123778,"source":{"system":"sec-edgar","filing":"0001127602-22-001726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222001726/form4.xml","form_type":"4"}},{"id":2431574,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-01-20T22:03:48.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":123547,"source":{"system":"sec-edgar","filing":"0001127602-22-001726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222001726/form4.xml","form_type":"4"}},{"id":2540002,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-10-19T13:27:07.000Z","date":"2021-10-18","kind":"grant","acquired":true,"shares":214,"price":66.46,"value":14222.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the \"Plan\"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On October 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment."}],"balance_after":123219,"source":{"system":"sec-edgar","filing":"0001127602-21-027249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221027249/form4.xml","form_type":"4"}},{"id":2540001,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-10-19T13:27:07.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $67.62. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":123005,"source":{"system":"sec-edgar","filing":"0001127602-21-027249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221027249/form4.xml","form_type":"4"}},{"id":2632639,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-07-16T18:50:31.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":178,"price":80.01,"value":14241.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the \"Plan\"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On July 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment."}],"balance_after":122707,"source":{"system":"sec-edgar","filing":"0001127602-21-022093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221022093/form4.xml","form_type":"4"}},{"id":2632638,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-07-16T18:50:31.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $79.89. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":122529,"source":{"system":"sec-edgar","filing":"0001127602-21-022093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221022093/form4.xml","form_type":"4"}},{"id":2721895,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-05-10T16:09:52.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":1757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":122278,"source":{"system":"sec-edgar","filing":"0001127602-21-015981","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221015981/form4.xml","form_type":"4"}},{"id":2746306,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-04-19T13:43:03.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":167,"price":84.27,"value":14073.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the \"Plan\"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment."}],"balance_after":120521,"source":{"system":"sec-edgar","filing":"0001127602-21-013950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221013950/form4.xml","form_type":"4"}},{"id":2746305,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-04-19T13:43:03.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":120354,"source":{"system":"sec-edgar","filing":"0001127602-21-013950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221013950/form4.xml","form_type":"4"}},{"id":2903580,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-01-20T17:31:47.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":172,"price":83.26,"value":14320.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the \"Plan\"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On January 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment."}],"balance_after":120118,"source":{"system":"sec-edgar","filing":"0001127602-21-002083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221002083/form4.xml","form_type":"4"}},{"id":2903579,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-01-20T17:31:47.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":119946,"source":{"system":"sec-edgar","filing":"0001127602-21-002083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221002083/form4.xml","form_type":"4"}},{"id":2921745,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:32:12.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":6531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted share unit represents the contingent right to receive one share of Norwegian Cruise Line Holdings Ltd.'s (\"NCLH\") common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted share units under NCLH's Amended and Restated 2013 Performance Incentive Plan. The restricted share units will vest in one installment on January 3, 2022."}],"balance_after":38318,"source":{"system":"sec-edgar","filing":"0001104659-21-000956","document":"tm211588-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000110465921000956/tm211588-2_4seq1.xml","form_type":"4"}},{"id":3003418,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-10-20T14:34:15.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":658,"price":68.41,"value":45013.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 456 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 202 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2019 to defer fixed percentages of their directors fees for 2020. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On October 15, 2020, the Company paid a dividend on common stock of $0.28 per share."}],"balance_after":119713,"source":{"system":"sec-edgar","filing":"0001127602-20-027241","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220027241/form4.xml","form_type":"4"}},{"id":3003417,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-10-20T14:34:15.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $68.11. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":119055,"source":{"system":"sec-edgar","filing":"0001127602-20-027241","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220027241/form4.xml","form_type":"4"}},{"id":3079833,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-07-20T21:03:20.000Z","date":"2020-07-20","kind":"grant","acquired":true,"shares":725,"price":63.91,"value":46334.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 511 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 214 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2019 to defer fixed percentages of their directors fees for 2020. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On July 15, 2020, the Company paid a dividend on common stock of $0.28 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $63.85 to $63.93, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":118770,"source":{"system":"sec-edgar","filing":"0001127602-20-021825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220021825/form4.xml","form_type":"4"}},{"id":3079832,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-07-20T21:03:20.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $65.21. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":118045,"source":{"system":"sec-edgar","filing":"0001127602-20-021825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220021825/form4.xml","form_type":"4"}},{"id":3158776,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-05-07T21:35:16.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":2304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":117750,"source":{"system":"sec-edgar","filing":"0001127602-20-015798","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220015798/form4.xml","form_type":"4"}},{"id":3174824,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-04-17T13:10:34.000Z","date":"2020-04-16","kind":"grant","acquired":true,"shares":607,"price":69.44,"value":42150.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 413 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 194 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2019 to defer fixed percentages of their directors fees for 2020. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On April 15, 2020, the Company paid a dividend on common stock of $0.28 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $69.43 to $69.45, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":115446,"source":{"system":"sec-edgar","filing":"0001127602-20-013952","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220013952/form4.xml","form_type":"4"}},{"id":3174823,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-04-17T13:10:34.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $69.76. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":114839,"source":{"system":"sec-edgar","filing":"0001127602-20-013952","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220013952/form4.xml","form_type":"4"}},{"id":3306934,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-01-21T14:12:04.000Z","date":"2020-01-17","kind":"grant","acquired":true,"shares":539,"price":79.28,"value":42731.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 369 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 170 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2019 to defer fixed percentages of their directors fees for 2020. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On January 15, 2020, the Company paid a dividend on common stock of $0.28 per share."}],"balance_after":114572,"source":{"system":"sec-edgar","filing":"0001127602-20-001987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220001987/form4.xml","form_type":"4"}},{"id":3306933,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-01-21T14:12:04.000Z","date":"2020-01-16","kind":"grant","acquired":true,"shares":238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $77.50. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":114033,"source":{"system":"sec-edgar","filing":"0001127602-20-001987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220001987/form4.xml","form_type":"4"}},{"id":3318928,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:39:25.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":4334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted share unit represents the contingent right to receive one share of Norwegian Cruise Line Holdings Ltd.'s (\"NCLH\") common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted share units under NCLH's Amended and Restated 2013 Performance Incentive Plan.  The restricted share units will vest in one installment on January 4, 2021."}],"balance_after":31787,"source":{"system":"sec-edgar","filing":"0001104659-20-001564","document":"tm201189d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000110465920001564/tm201189d3_4.xml","form_type":"4"}},{"id":3392527,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-10-17T15:16:56.000Z","date":"2019-10-16","kind":"grant","acquired":true,"shares":205,"price":64.87,"value":13298.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the \"Plan\"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On October 15, 2019, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment."}],"balance_after":113795,"source":{"system":"sec-edgar","filing":"0001127602-19-030667","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219030667/form4.xml","form_type":"4"}},{"id":3392526,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-10-17T15:16:56.000Z","date":"2019-10-16","kind":"grant","acquired":true,"shares":285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2019, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $64.71. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":113590,"source":{"system":"sec-edgar","filing":"0001127602-19-030667","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219030667/form4.xml","form_type":"4"}},{"id":3460343,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-07-17T21:58:12.000Z","date":"2019-07-16","kind":"grant","acquired":true,"shares":198,"price":64.28,"value":12727.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the \"Plan\"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On July 15, 2019, the Company paid a dividend on common stock of $0.27 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment."}],"balance_after":113305,"source":{"system":"sec-edgar","filing":"0001127602-19-024788","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219024788/form4.xml","form_type":"4"}},{"id":3460342,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-07-17T21:58:12.000Z","date":"2019-07-16","kind":"grant","acquired":true,"shares":275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $64.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":113107,"source":{"system":"sec-edgar","filing":"0001127602-19-024788","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219024788/form4.xml","form_type":"4"}},{"id":3537128,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-05-07T15:57:27.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":2327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":112832,"source":{"system":"sec-edgar","filing":"0001127602-19-017539","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219017539/form4.xml","form_type":"4"}},{"id":3550532,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-04-24T13:05:21.000Z","date":"2019-04-23","kind":"grant","acquired":true,"shares":210,"price":61.3,"value":12873.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the \"Plan\"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 15, 2019, the Company paid a dividend on common stock of $0.27 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment."}],"balance_after":110228,"source":{"system":"sec-edgar","filing":"0001127602-19-016093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219016093/form4.xml","form_type":"4"}},{"id":3550531,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-04-24T13:05:21.000Z","date":"2019-04-23","kind":"grant","acquired":true,"shares":277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":110505,"source":{"system":"sec-edgar","filing":"0001127602-19-016093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219016093/form4.xml","form_type":"4"}},{"id":3666955,"issuer":{"id":779,"kind":"organization","name":"BRINKER INTERNATIONAL, INC","symbol":"EAT"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-11T23:12:57.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":1890,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1890,"source":{"system":"sec-edgar","filing":"0001209191-19-009092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/703351/000120919119009092/doc4.xml","form_type":"4"}},{"id":3695019,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-01-16T21:06:28.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":196,"price":66.48,"value":13030.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the \"Plan\"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On January 15, 2019, the Company paid a dividend on common stock of $0.27 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment."}],"balance_after":110018,"source":{"system":"sec-edgar","filing":"0001127602-19-002119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219002119/form4.xml","form_type":"4"}},{"id":3695018,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-01-16T21:06:28.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":109822,"source":{"system":"sec-edgar","filing":"0001127602-19-002119","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219002119/form4.xml","form_type":"4"}},{"id":3705087,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T21:47:14.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":5663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted share unit represents the contingent right to receive one share of Norwegian Cruise Line Holdings Ltd.'s (\"NCLH\") common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted share units under NCLH's Amended and Restated 2013 Performance Incentive Plan. The restricted share units will vest in one installment on January 2, 2020."}],"balance_after":27453,"source":{"system":"sec-edgar","filing":"0001144204-19-000679","document":"tv510306_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000114420419000679/tv510306_4.xml","form_type":"4"}},{"id":3789360,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-10-17T19:54:01.000Z","date":"2018-10-16","kind":"grant","acquired":true,"shares":538,"price":75.26,"value":40489.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 373 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 165 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2017 to defer fixed percentages of their directors fees for 2018. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On October 15, 2018, the Company paid a dividend on common stock of $0.27 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.26 to $75.27, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range."}],"balance_after":109565,"source":{"system":"sec-edgar","filing":"0001127602-18-030489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218030489/form4.xml","form_type":"4"}},{"id":3789359,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-10-17T19:54:01.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2018, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":109027,"source":{"system":"sec-edgar","filing":"0001127602-18-030489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218030489/form4.xml","form_type":"4"}},{"id":3865737,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-07-18T19:58:24.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":603,"price":68.8,"value":41486.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 437 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 166 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2017 to defer fixed percentages of their directors fees for 2018. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On July 16, 2018, the Company paid a dividend on common stock of $0.25 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.79 to $68.80, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range."}],"balance_after":108800,"source":{"system":"sec-edgar","filing":"0001127602-18-023475","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218023475/form4.xml","form_type":"4"}},{"id":3865736,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-07-18T19:58:24.000Z","date":"2018-07-16","kind":"grant","acquired":true,"shares":226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":108197,"source":{"system":"sec-edgar","filing":"0001127602-18-023475","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218023475/form4.xml","form_type":"4"}},{"id":3944888,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-05-07T20:56:52.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":2386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":107971,"source":{"system":"sec-edgar","filing":"0001127602-18-016514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218016514/form4.xml","form_type":"4"}},{"id":3961526,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2018-04-18T22:29:37.000Z","date":"2018-04-17","kind":"grant","acquired":true,"shares":626,"price":57.99,"value":36301.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 431 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 195 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2017 to defer fixed percentages of their directors fees for 2018. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On April 16, 2018, the Company paid a dividend on common stock of $0.25 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $57.98 to $57.99, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":105585,"source":{"system":"sec-edgar","filing":"0001127602-18-014895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218014895/form4.xml","form_type":"4"}},{"id":3961525,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2018-04-18T22:29:37.000Z","date":"2018-04-16","kind":"grant","acquired":true,"shares":261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":104959,"source":{"system":"sec-edgar","filing":"0001127602-18-014895","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218014895/form4.xml","form_type":"4"}},{"id":4097193,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2018-01-18T21:38:28.000Z","date":"2018-01-18","kind":"grant","acquired":true,"shares":695,"price":51.88,"value":36056.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 481 shares of common stock of Encompass Health Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 214 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2017 to defer fixed percentages of their directors fees for 2018. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On January 16, 2018, the Company paid a dividend on common stock of $0.25 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $51.87 to $51.88, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":104698,"source":{"system":"sec-edgar","filing":"0001127602-18-002074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218002074/form4.xml","form_type":"4"}},{"id":4097192,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2018-01-18T21:38:28.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":104003,"source":{"system":"sec-edgar","filing":"0001127602-18-002074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218002074/form4.xml","form_type":"4"}},{"id":4108019,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T21:41:55.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":4366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted share unit represents the contingent right to receive one share of Norwegian Cruise Line Holdings Ltd.'s (\"NCLH\") common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted share units under NCLH's Amended and Restated 2013 Performance Incentive Plan.  The restricted share units will vest in one installment on January 2, 2019"}],"balance_after":21790,"source":{"system":"sec-edgar","filing":"0001144204-18-000836","document":"tv482631_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000114420418000836/tv482631_form4.xml","form_type":"4"}},{"id":4184334,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-10-18T15:56:39.000Z","date":"2017-10-17","kind":"grant","acquired":true,"shares":794,"price":45.15,"value":35849.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 552 shares of common stock of HealthSouth Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 242 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2016 to defer fixed percentages of their directors fees for 2017. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On October 16, 2017, the Company paid a dividend on common stock of $0.25 per share."}],"balance_after":103715,"source":{"system":"sec-edgar","filing":"0001127602-17-029990","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217029990/form4.xml","form_type":"4"}},{"id":4184333,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-10-18T15:56:39.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2017, HealthSouth paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":102921,"source":{"system":"sec-edgar","filing":"0001127602-17-029990","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217029990/form4.xml","form_type":"4"}},{"id":4254925,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-07-19T18:49:01.000Z","date":"2017-07-18","kind":"grant","acquired":true,"shares":768,"price":45.875,"value":35232.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 544 shares of common stock of HealthSouth Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 224 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2016 to defer fixed percentages of their directors fees for 2017. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On July 17, 2017, the Company paid a dividend on common stock of $0.24 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $45.8199 to $46.009, inclusive. The reporting person undertakes to provide to HealthSouth Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":102594,"source":{"system":"sec-edgar","filing":"0001127602-17-023855","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217023855/form4.xml","form_type":"4"}},{"id":4254924,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-07-19T18:49:01.000Z","date":"2017-07-17","kind":"grant","acquired":true,"shares":306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":101826,"source":{"system":"sec-edgar","filing":"0001127602-17-023855","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217023855/form4.xml","form_type":"4"}},{"id":4332536,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-05-05T20:03:04.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":3066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":101520,"source":{"system":"sec-edgar","filing":"0001127602-17-017053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217017053/form4.xml","form_type":"4"}},{"id":4350246,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-04-19T19:40:08.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":769,"price":44,"value":33836.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 540 shares of common stock of HealthSouth Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 229 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2016 to defer fixed percentages of their directors fees for 2017. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On April 17, 2017, the Company paid a dividend on common stock of $0.24 per share."}],"balance_after":98454,"source":{"system":"sec-edgar","filing":"0001127602-17-015053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217015053/form4.xml","form_type":"4"}},{"id":4350245,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-04-19T19:40:08.000Z","date":"2017-04-17","kind":"grant","acquired":true,"shares":303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates.  The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":97685,"source":{"system":"sec-edgar","filing":"0001127602-17-015053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217015053/form4.xml","form_type":"4"}},{"id":4487369,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-01-19T19:08:28.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":848,"price":41.15,"value":34895.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 606 shares of common stock of HealthSouth Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 242 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2016 to defer fixed percentages of their directors fees for 2017. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On January 17, 2017, the Company paid a dividend on common stock of $0.24 per share."}],"balance_after":97382,"source":{"system":"sec-edgar","filing":"0001127602-17-001998","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217001998/form4.xml","form_type":"4"}},{"id":4487368,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2017-01-19T19:08:28.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates.  The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":96534,"source":{"system":"sec-edgar","filing":"0001127602-17-001998","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760217001998/form4.xml","form_type":"4"}},{"id":4499067,"issuer":{"id":3699,"kind":"organization","name":"Norwegian Cruise Line Holdings Ltd."},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T21:48:58.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":5258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted share unit represents the contingent right to receive one share of Norwegian Cruise Line Holdings Ltd.'s (\"NCLH\") common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted share units under NCLH's Amended and Restated 2013 Performance Incentive Plan. The restricted share units will vest in one installment on January 2, 2018."}],"balance_after":17424,"source":{"system":"sec-edgar","filing":"0001571049-17-000192","document":"t1700011_x3-f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1128484/000157104917000192/t1700011_x3-f4.xml","form_type":"4"}},{"id":4577886,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2016-10-19T17:52:57.000Z","date":"2016-10-18","kind":"grant","acquired":true,"shares":741,"price":40.27,"value":29840.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This number represents the purchase of (a) 499 shares of common stock of HealthSouth Corporation (the \"Company\") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the \"Plan\") and (b) 242 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2015 to defer fixed percentages of their directors fees for 2016. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On October 17, 2016, the Company paid a dividend on common stock of $0.24 per share. The transactions reported on this Form 4 are the acquisitions under the Plan of shares of common stock of the Company in the market for the account of the reporting person for an aggregate purchase price equal to the sum of (i) the amount of fees deferred by the reporting person and (ii) the cumulative dividends paid on the common stock held in the associated deferred account."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.235 to $40.339, inclusive. The reporting person undertakes to provide to HealthSouth Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range."}],"balance_after":96218,"source":{"system":"sec-edgar","filing":"0001127602-16-064997","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760216064997/form4.xml","form_type":"4"}},{"id":4577885,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true}}],"security":"Healthsouth Common Stock","published_at":"2016-10-19T17:52:57.000Z","date":"2016-10-17","kind":"grant","acquired":true,"shares":328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates.  The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2016, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":95477,"source":{"system":"sec-edgar","filing":"0001127602-16-064997","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760216064997/form4.xml","form_type":"4"}}]}